Technology based innovative life-science company committed to pursuing
for healthier and cleaner world
Attracted the third round external capital funding.
Established MOU with Korea Atomic Energy Research Institute (KAERI), Yonsei University
(Department of Pharmacy), and Chonnam National University (College of Veterinary Medicin).
Established MOU with Asan Medical center and Konkuk University Bioimaging Center.
Attracted the second round external capital funding.
Attracted the first round external capital funding.
Change company name to BioActs, secure external fund.
Established distributorship agreement and MOU with Seoulin Bioscience Inc.
Selected as a member of K-club of Korea Institute of Science and Technology.
Recognized as a Visionary Company by Incheon Metropolitan city.
Established MOU between BioActs and National Institute of Imaging and
Bioengineering, an affiliated institute of NIH.
Biological division business marketing and sales launched.
Established MOU with Chonnam National University Hwasun Hospital.
Certified as an Advanced Technology Center (ATC) for biomolecular labeling materials.
The New Excellent Technology (NET) certification acquired
Biological business division (BioActs) established.
Antibacterial dyes and blue fluorescent OLED material production begin.
Ningbo Factory and Hangzhou Sales Corporation in China launched.
Awarded the presidential commendation and 5 million dollars export tower.
Affiliated R&D center established; opened an era of innovative growth.
Corporation established; opened an era of creation and exploration.